Inhibikase Therapeutics, Inc. (IKT) SEC Filings https://www.inhibikase.com/investors/sec-filings/all-sec-filings/rss Inhibikase Therapeutics, Inc. (IKT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_36dbb71928886c79e446b0ffcae1c0b0/inhibikase/files/theme/images/logo-sm.png Inhibikase Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-062874/0001104659-26-062874.pdf Fri, 15 May 26 20:13:31 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-062874/0001104659-26-062874.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001493152-26-023791/0001493152-26-023791.pdf Fri, 15 May 26 16:31:49 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001493152-26-023791/0001493152-26-023791.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001831942-26-000019/0001831942-26-000019.pdf Fri, 15 May 26 16:21:19 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001831942-26-000019/0001831942-26-000019.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-226561/0001193125-26-226561.pdf Fri, 15 May 26 16:01:02 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-226561/0001193125-26-226561.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-219641/0001193125-26-219641.pdf Tue, 12 May 26 16:45:04 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-219641/0001193125-26-219641.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-219610/0001193125-26-219610.pdf Tue, 12 May 26 16:41:02 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-219610/0001193125-26-219610.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-197321/0001193125-26-197321.pdf Thu, 30 Apr 26 16:19:22 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-197321/0001193125-26-197321.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-197279/0001193125-26-197279.pdf Thu, 30 Apr 26 16:15:15 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-197279/0001193125-26-197279.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-197177/0001193125-26-197177.pdf Thu, 30 Apr 26 16:08:33 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-197177/0001193125-26-197177.pdf <![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-163935/0001193125-26-163935.pdf Mon, 20 Apr 26 16:06:24 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-163935/0001193125-26-163935.pdf